193 related articles for article (PubMed ID: 22000745)
1. Positron emission tomography/computed tomography in the staging and treatment of anal cancer.
Sveistrup J; Loft A; Berthelsen AK; Henriksen BM; Nielsen MB; Engelholm SA
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):134-41. PubMed ID: 22000745
[TBL] [Abstract][Full Text] [Related]
2. Role of positron emission tomography-computed tomography in the management of anal cancer.
Mistrangelo M; Pelosi E; Bellò M; Ricardi U; Milanesi E; Cassoni P; Baccega M; Filippini C; Racca P; Lesca A; Munoz FH; Fora G; Skanjeti A; Cravero F; Morino M
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):66-72. PubMed ID: 22592047
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181
[TBL] [Abstract][Full Text] [Related]
4. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer.
Mistrangelo M; Pelosi E; Bellò M; Castellano I; Cassoni P; Ricardi U; Munoz F; Racca P; Contu V; Beltramo G; Morino M; Mussa A
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):73-8. PubMed ID: 19632066
[TBL] [Abstract][Full Text] [Related]
5. FDG-PET/CT in the evaluation of anal carcinoma.
Cotter SE; Grigsby PW; Siegel BA; Dehdashti F; Malyapa RS; Fleshman JW; Birnbaum EH; Wang X; Abbey E; Tan B; Kodner IJ; Hunt SR; Lowney JK; Mutch MG; Dietz DW; Myerson RJ
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):720-5. PubMed ID: 16626889
[TBL] [Abstract][Full Text] [Related]
6. External ultrasonography of the neck does not add diagnostic value to integrated positron emission tomography-computed tomography (PET-CT) scanning in the diagnosis of cervical lymph node metastases in patients with esophageal carcinoma.
Blom RL; Vliegen RF; Schreurs WM; Belgers HJ; Stohr I; Oostenbrug LE; Sosef MN
Dis Esophagus; 2012 Aug; 25(6):555-9. PubMed ID: 22150869
[TBL] [Abstract][Full Text] [Related]
7. The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis.
Jones M; Hruby G; Solomon M; Rutherford N; Martin J
Ann Surg Oncol; 2015 Oct; 22(11):3574-81. PubMed ID: 25652048
[TBL] [Abstract][Full Text] [Related]
8. Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: a prospective single-center study.
Schlenker B; Scher B; Tiling R; Siegert S; Hungerhuber E; Gratzke C; Tilki D; Reich O; Schneede P; Bartenstein P; Stief CG; Seitz M
Urol Oncol; 2012; 30(1):55-9. PubMed ID: 20022269
[TBL] [Abstract][Full Text] [Related]
9. Sentinel node biopsy in squamous-cell carcinoma of the anal canal.
De Nardi P; Carvello M; Canevari C; Passoni P; Staudacher C
Ann Surg Oncol; 2011 Feb; 18(2):365-70. PubMed ID: 20803079
[TBL] [Abstract][Full Text] [Related]
10. PET/CT in anal cancer - is it worth doing?
Wells IT; Fox BM
Clin Radiol; 2012 Jun; 67(6):535-40. PubMed ID: 22208962
[TBL] [Abstract][Full Text] [Related]
11. Assessing the impact of FDG-PET in the management of anal cancer.
Nguyen BT; Joon DL; Khoo V; Quong G; Chao M; Wada M; Joon ML; See A; Feigen M; Rykers K; Kai C; Zupan E; Scott A
Radiother Oncol; 2008 Jun; 87(3):376-82. PubMed ID: 18453023
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of fluorodeoxyglucose positron emission tomography/computed tomography and inguinal sentinel lymph node biopsy in patients with anal cancer.
De Nardi P; Guarneri G; Canevari C; Tamburini A; Slim N; Passoni P; Rosati R
Colorectal Dis; 2019 Sep; 21(9):1017-1024. PubMed ID: 31077550
[TBL] [Abstract][Full Text] [Related]
13. [Positron emission tomography/computed tomography for lung cancer staging].
Ladrón de Guevara H D; Furnaro L F; Yévenes A S; Clavero R JM; Lazo P D; Rodríguez D P; Piottante B A; Pefaur D R; Pardo B C
Rev Med Chil; 2015 Jan; 143(1):22-9. PubMed ID: 25860265
[TBL] [Abstract][Full Text] [Related]
14. The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer.
Winton Ed; Heriot AG; Ng M; Hicks RJ; Hogg A; Milner A; Leong T; Fay M; MacKay J; Drummond E; Ngan SY
Br J Cancer; 2009 Mar; 100(5):693-700. PubMed ID: 19259091
[TBL] [Abstract][Full Text] [Related]
15. Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines.
Dapper H; Schiller K; Münch S; Peeken JC; Borm K; Weber W; Combs SE
BMC Cancer; 2019 Jul; 19(1):742. PubMed ID: 31357959
[TBL] [Abstract][Full Text] [Related]
16. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
[TBL] [Abstract][Full Text] [Related]
17. Comparison between pelvic MRI, CT, and PET/CT in baseline staging and radiation planning of anal squamous cell carcinoma.
Horvat N; Jayaprakasam VS; Crane CH; Zheng J; Gangai N; Romesser PB; Golia Pernicka JS; Capanu M; Gollub MJ
Abdom Radiol (NY); 2024 May; 49(5):1351-1362. PubMed ID: 38456896
[TBL] [Abstract][Full Text] [Related]
18. [Impact of (18)F-FDG PET/CT on the therapeutic management in the initial staging of the esophageal cancer].
Pifarré-Montaner P; Fernández-León A; de Juan R; del Ama-Salvador ME; Galán M; Gámez-Cenzano C; Sans M
Rev Esp Med Nucl; 2009; 28(3):101-5. PubMed ID: 19558949
[TBL] [Abstract][Full Text] [Related]
19. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
[TBL] [Abstract][Full Text] [Related]
20. Utility of ¹⁸F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes.
Rosevear HM; Williams H; Collins M; Lightfoot AJ; Coleman T; Brown JA
Urol Oncol; 2012 Sep; 30(5):723-6. PubMed ID: 21396850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]